Skip to main content

Table 2 Features of the metabolic syndrome in patients with and without elevated liver aminotransferases

From: Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound

 

Diabetic patients

  

Variables (n, %)

without increased

ALT

(n = 479)

with increased

ALT

(n = 191)

Crude OR

(95% CI)

Adjusted OR

(95% CI)

High blood pressure

203 (42.4)

91 (47.6)

1.24 (0.88-1.73)

1.11 (0.68-1.80) 1

High triglycerides

286 (59.7)

135 (70.7)

1.63 (1.13-2.33)*

1.50 (0.91-2.48) 1

Low HDL-C

256 (53.4)

133 (69.6)

2.00 (1.40-2.58)***

2.04 (1.24-3.38) **1

High waist circumference

368 (26.8)

171 (89.5)

2.56 (1.53-4.26)***

2.48 (1.20-5.11) *1

MetS

341 (71.2)

161 (84.3)

2.17 (1.40-3.36)***

2.08 (1.12-3.87) *1

 

without increased

AST

(n = 576)

with increased

AST

(n = 94)

  

High blood pressure

249 (43.2)

45 (47.9)

1.21 (0.78-1.87)

1.05 (0.56-1.98) 2

High triglycerides

354 (61.4)

67 (71.3)

1.56 (0.97-2.51)

1.39 (0.71-2.73) 2

Low HDL-C

320 (55.6)

69 (73.4)

2.21 (1.36-3.59)**

2.13 (1.06-4.31) *2

High waist circumference

405 (70.3)

84 (89.4)

2.23 (1.12-4.43)*

2.17 (0.89-5.31) 2

MetS

421 (73.1)

81 (86.2)

2.31 (1.25-4.27)**

2.23 (1.09-4.57) *2

  1. *P < 0.05, **P < 0.01, ***P < 0.001
  2. 1Adjusted for age, sex, BMI, diabetes duration, HbA1c and medications (anti diabetic, lipid lowering or antihypertensive agents)
  3. 2Adjusted for age, sex, BMI, diabetes duration, HbA1c and medications (anti diabetic, lipid lowering or antihypertensive agents)